28bio, Inc.
4 private offerings reported to the SEC on Form D since 2016, $19.4M sold in all. Biotech, Louisiana.
- Form D offerings: 4
- Reported sold: $19.4M
- Newest: Jun 24, 2025
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Jun 24, 2025 | — | $8.5M | $8.5M | AxoSim, Inc.Biotech · Louisiana | Oct 29, 2026 | 0001769360-25-000001 |
| Nov 22, 2024 | — | $3.7M | $4.8M | AxoSim, Inc.Biotech · Louisiana | Not amended | 0001769360-24-000003 |
| Jun 15, 2020 | — | $6.1M | $6.1M | AxoSim, Inc.Biotech · Louisiana | Jun 10, 2021 | 0001769360-20-000001 |
| Mar 5, 2019 | — | $1.1M | $2.5M | AxoSim, Inc.Biotech · Louisiana | Not amended | 0001769360-19-000001 |
- Business address
- Metairie, La
- Incorporated in
- Delaware
- Former names
- AxoSim, Inc.
- All SEC filings
- CIK 1769360 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR